ELV Elevance Health
NYSE · SEC CIK 1156039 · EDGAR
- Bought, last 12 months
- $2.24M 3 purchases by 3 insiders
- Sold, last 12 months
- $1.74M 5 sales by 4 insiders
- Filings on record
- 154 since 2021-07-07, latest 2026-09-04 16:06
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| BOUDREAUX GAIL | Pres, CEO, Dir | $1.00M | — |
| Kendrick Charles Morgan JR | EVP, Pres, Commercial | — | $910.6K |
| COLLIS STEVEN H | Dir | $869.5K | — |
| Penczek Ronald W | CAO, Ctrl | — | $766.0K |
| PERU RAMIRO G | Dir | $366.1K | — |
| Dixon Robert L JR | Dir | — | $60.7K |
| SCHULMAN AMY W | Dir | — | $7,475 |
| Wessling Erin M | EVP, CLO | — | — |
| Craig Ryan R | EVP, Chief HR Off | — | — |
| Kaye Mark | EVP, CFO | — | — |
Transactions 207
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-05 | 2024-03-01 | ELV | Kaye Mark | EVP, CFO | A - Grant | $0.00 | +2,755 | 23.0K | +14% | $0 |
| DM | 2024-03-05 | 2024-03-01 | ELV | BOUDREAUX GAIL | Pres, CEO, Dir | A - Grant | $0.00 | +42.9K | 160.7K | +36% | $0 |
| D | 2024-03-05 | 2024-03-01 | ELV | BOUDREAUX GAIL | Pres, CEO, Dir | F - Tax | $499.11 | -19.3K | 117.8K | -14% | -$9.61M |
| DM | 2024-03-05 | 2024-03-01 | ELV | Haytaian Peter D | EVP, Pres Carelon, CarelonRx | A - Grant | $0.00 | +11.6K | 25.0K | +86% | $0 |
| DM | 2024-03-05 | 2024-03-04 | ELV | Haytaian Peter D | EVP, Pres Carelon, CarelonRx | S - Sale+OE | $500.18 | -21.1K | 35.8K | -37% | -$10.55M |
| D | 2024-03-05 | 2024-03-04 | ELV | Haytaian Peter D | EVP, Pres Carelon, CarelonRx | M - OptEx | $166.97 | +15.0K | 40.0K | +60% | +$2.50M |
| D | 2024-03-05 | 2024-03-01 | ELV | Haytaian Peter D | EVP, Pres Carelon, CarelonRx | F - Tax | $499.11 | -4,314 | 13.4K | -24% | -$2.15M |
| DM | 2024-03-05 | 2024-03-01 | ELV | LAVU RATNAKAR | EVP, Chief Digital Off | A - Grant | $0.00 | +2,756 | 1,754 | New | $0 |
| D | 2024-03-05 | 2024-03-01 | ELV | Norwood Felicia F | EVP, Pres, Gov Health Ben | F - Tax | $499.11 | -4,902 | 28.5K | -15% | -$2.45M |
| DM | 2024-03-05 | 2024-03-01 | ELV | Norwood Felicia F | EVP, Pres, Gov Health Ben | A - Grant | $0.00 | +11.6K | 30.9K | +60% | $0 |
| D | 2024-03-05 | 2024-03-01 | ELV | Penczek Ronald W | CAO, Ctrl | F - Tax | $499.11 | -383 | 1,408 | -21% | -$191.2K |
| DM | 2024-03-05 | 2024-03-01 | ELV | Penczek Ronald W | CAO, Ctrl | A - Grant | $0.00 | +1,272 | 2,680 | +90% | $0 |
| DM | 2024-03-05 | 2024-03-01 | ELV | Todt Blair Williams | EVP, CLO, CAO | A - Grant | $0.00 | +8,691 | 10.6K | +451% | $0 |
| D | 2024-03-05 | 2024-03-01 | ELV | Todt Blair Williams | EVP, CLO, CAO | F - Tax | $499.11 | -3,650 | 8,465 | -30% | -$1.82M |
| 2024-02-09 | 2024-02-07 | ELV | PERU RAMIRO G | Dir | S - Sale | $500.00 | -753 | 9,109 | -8% | -$376.5K | |
| 2024-01-05 | 2024-01-03 | ELV | Todt Blair Williams | EVP, CLO, CAO | F - Tax | $480.49 | -397 | 12.1K | -3% | -$190.8K | |
| D | 2023-12-15 | 2023-12-14 | ELV | Todt Blair Williams | EVP, CLO, CAO | M - OptEx | $311.48 | +5,492 | 18.0K | +44% | +$1.71M |
| D | 2023-12-15 | 2023-12-14 | ELV | Todt Blair Williams | EVP, CLO, CAO | S - Sale+OE | $484.02 | -5,492 | 12.5K | -31% | -$2.66M |
| 2023-12-05 | 2023-12-01 | ELV | Todt Blair Williams | EVP, CLO, CAO | F - Tax | $483.12 | -116 | 12.5K | -0.9% | -$56.0K | |
| 2023-12-01 | 2023-11-30 | ELV | Penczek Ronald W | CAO, Ctrl | S - Sale | $475.17 | -1,055 | 1,787 | -37% | -$501.3K | |
| 2023-11-03 | 2023-11-01 | ELV | Kendrick Charles Morgan JR | EVP, Pres, Commercial | F - Tax | $446.66 | -79 | 15.2K | -0.5% | -$35.3K | |
| 2023-11-03 | 2023-11-01 | ELV | Haytaian Peter D | EVP, Pres Carelon, CarelonRx | F - Tax | $446.66 | -154 | 17.7K | -0.9% | -$68.8K | |
| 2023-10-26 | 2023-10-24 | ELV | Penczek Ronald W | CAO, Ctrl | S - Sale | $454.35 | -64 | 2,842 | -2% | -$29.1K | |
| DM | 2023-10-04 | 2023-10-02 | ELV | Kaye Mark | EVP, CFO Designate | A - Grant | $0.00 | +20.3K | 18.2K | New | $0 |
| 2023-07-21 | 2023-07-21 | ELV | Dixon Robert L JR | Dir | S - Sale | $476.71 | -310 | 9,638 | -3% | -$147.8K | |
| 2023-05-12 | 2023-05-10 | ELV | Schneider Ryan M. | Dir | A - Grant | $0.00 | +457 | 5,611 | +9% | $0 | |
| 2023-05-12 | 2023-05-10 | ELV | Dixon Robert L JR | Dir | A - Grant | $0.00 | +457 | 9,948 | +5% | $0 | |
| 2023-05-12 | 2023-05-10 | ELV | Tallett Elizabeth E | Dir | A - Grant | $0.00 | +457 | 9,903 | +5% | $0 | |
| 2023-05-12 | 2023-05-10 | ELV | Jallal Bahija | Dir | A - Grant | $0.00 | +457 | 3,799 | +14% | $0 | |
| 2023-05-12 | 2023-05-10 | ELV | PERU RAMIRO G | Dir | A - Grant | $0.00 | +457 | 9,862 | +5% | $0 | |
| 2023-05-12 | 2023-05-10 | ELV | CLARK R KERRY | Dir | A - Grant | $0.00 | +457 | 8,651 | +6% | $0 | |
| 2023-05-12 | 2023-05-10 | ELV | STRABLE-SOETHOUT DEANNA D | Dir | A - Grant | $0.00 | +457 | 657 | +228% | $0 | |
| 2023-05-12 | 2023-05-10 | ELV | Neri Antonio F | Dir | A - Grant | $0.00 | +457 | 3,936 | +13% | $0 | |
| 2023-05-12 | 2023-05-10 | ELV | DeVore Susan D. | Dir | A - Grant | $0.00 | +457 | 1,313 | +53% | $0 | |
| 2023-05-12 | 2023-05-10 | ELV | HAY LEWIS III | Dir | A - Grant | $0.00 | +457 | 10.5K | +5% | $0 | |
| M | 2023-03-27 | 2023-03-24 | ELV | MCCARTHY GLORIA M | EVP, Chief Administrative Off | S - Sale | $444.76 | -15.1K | 63.6K | -19% | -$6.71M |
| 2023-03-13 | 2023-03-09 | ELV | Kendrick Charles Morgan JR | EVP, Pres, Commercial | S - Sale | $462.22 | -2,314 | 15.3K | -13% | -$1.07M | |
| DM | 2023-03-03 | 2023-03-01+ | ELV | Norwood Felicia F | EVP, Pres, GBD | F - Tax | $468.80 | -5,249 | 33.4K | -14% | -$2.46M |
| DM | 2023-03-03 | 2023-03-01 | ELV | Norwood Felicia F | EVP, Pres, GBD | A - Grant | $0.00 | +12.0K | 38.2K | +46% | $0 |
| DM | 2023-03-03 | 2023-03-01+ | ELV | Haytaian Peter D | EVP, Pres Carelon, CarelonRx | F - Tax | $468.80 | -6,076 | 11.4K | -35% | -$2.85M |
| DM | 2023-03-03 | 2023-03-01 | ELV | Haytaian Peter D | EVP, Pres Carelon, CarelonRx | A - Grant | $0.00 | +12.0K | 23.4K | +106% | $0 |
| DM | 2023-03-03 | 2023-03-01+ | ELV | Penczek Ronald W | CAO, Ctrl | F - Tax | $468.82 | -444 | 1,853 | -19% | -$208.2K |
| DM | 2023-03-03 | 2023-03-01 | ELV | Penczek Ronald W | CAO, Ctrl | A - Grant | $0.00 | +1,409 | 3,262 | +76% | $0 |
| DM | 2023-03-03 | 2023-03-01 | ELV | BOUDREAUX GAIL | Pres, CEO, Dir | A - Grant | $0.00 | +44.3K | 153.5K | +41% | $0 |
| DM | 2023-03-03 | 2023-03-01+ | ELV | BOUDREAUX GAIL | Pres, CEO, Dir | F - Tax | $468.81 | -20.1K | 109.2K | -16% | -$9.42M |
| DM | 2023-03-03 | 2023-03-01+ | ELV | Kendrick Charles Morgan JR | EVP, Pres, Commercial | F - Tax | $468.83 | -1,377 | 14.2K | -9% | -$645.6K |
| DM | 2023-03-03 | 2023-03-01 | ELV | Kendrick Charles Morgan JR | EVP, Pres, Commercial | A - Grant | $0.00 | +4,568 | 18.7K | +32% | $0 |
| DM | 2023-03-03 | 2023-03-01 | ELV | MCCARTHY GLORIA M | EVP, Chief Administrative Off | A - Grant | $0.00 | +11.8K | 72.0K | +20% | $0 |
| DM | 2023-03-03 | 2023-03-01+ | ELV | MCCARTHY GLORIA M | EVP, Chief Administrative Off | F - Tax | $468.81 | -6,047 | 66.5K | -8% | -$2.83M |
| DM | 2023-03-03 | 2023-03-01+ | ELV | Gallina John E | EVP, CFO | F - Tax | $468.81 | -5,237 | 63.7K | -8% | -$2.46M |
| DM | 2023-03-03 | 2023-03-01 | ELV | Gallina John E | EVP, CFO | A - Grant | $0.00 | +12.8K | 68.4K | +23% | $0 |
| D | 2023-03-03 | 2023-03-01 | ELV | Todt Blair Williams | EVP, CLO | F - Tax | $469.03 | -372 | 7,911 | -4% | -$174.5K |
| DM | 2023-03-03 | 2023-03-01 | ELV | Todt Blair Williams | EVP, CLO | A - Grant | $0.00 | +4,717 | 12.6K | +60% | $0 |
| 2023-01-05 | 2023-01-03 | ELV | Todt Blair Williams | EVP, CLO | A - Grant | $0.00 | +3,983 | 8,283 | +93% | $0 | |
| 2023-01-04 | 2022-12-30 | ELV | Norwood Felicia F | EVP, Pres, GBD | F - Tax | $512.97 | -1,754 | 26.7K | -6% | -$899.7K | |
| 2022-12-05 | 2022-12-01 | ELV | Todt Blair Williams | EVP, CLO | F - Tax | $525.25 | -117 | 4,300 | -3% | -$61.5K | |
| 2022-11-04 | 2022-11-04 | ELV | BOUDREAUX GAIL | Pres, CEO, Dir | G - Gift | $0.00 | -10.0K | 111.4K | -8% | $0 | |
| 2022-11-03 | 2022-11-01 | ELV | Haytaian Peter D | EVP, Pres Carelon, IngenioRx | F - Tax | $544.53 | -200 | 12.0K | -2% | -$108.9K | |
| 2022-11-03 | 2022-11-01 | ELV | Kendrick Charles Morgan JR | EVP, Pres, Commercial | F - Tax | $544.53 | -79 | 14.4K | -0.5% | -$43.0K | |
| 2022-11-02 | 2022-11-01 | ELV | STRABLE-SOETHOUT DEANNA D | Dir | A - Grant | $0.00 | +200 | 200 | New | $0 | |
| DM | 2022-06-13 | 2022-06-09 | ELV | Kendrick Charles Morgan JR | EVP, Pres, Commercial | M - OptEx | $285.52 | +6,328 | 16.5K | +62% | +$1.81M |
| DM | 2022-06-13 | 2022-06-09 | ELV | Kendrick Charles Morgan JR | EVP, Pres, Commercial | S - Sale+OE | $488.60 | -6,328 | 18.7K | -25% | -$3.09M |
| 2022-06-07 | 2022-06-06 | ELV | Dixon Robert L JR | Dir | S - Sale | $497.14 | -420 | 9,491 | -4% | -$208.8K | |
| 2022-05-20 | 2022-05-18 | ELV | Dixon Robert L JR | Dir | A - Grant | $0.00 | +440 | 9,911 | +5% | $0 | |
| 2022-05-20 | 2022-05-18 | ELV | PERU RAMIRO G | Dir | A - Grant | $0.00 | +440 | 10.4K | +4% | $0 | |
| 2022-05-20 | 2022-05-19 | ELV | PERU RAMIRO G | Dir | S - Sale | $468.88 | -990 | 9,405 | -10% | -$464.2K | |
| 2022-05-20 | 2022-05-18 | ELV | DeVore Susan D. | Dir | A - Grant | $0.00 | +440 | 856 | +106% | $0 | |
| 2022-05-20 | 2022-05-18 | ELV | Jallal Bahija | Dir | A - Grant | $0.00 | +440 | 3,342 | +15% | $0 | |
| 2022-05-20 | 2022-05-18 | ELV | Tallett Elizabeth E | Dir | A - Grant | $0.00 | +440 | 9,446 | +5% | $0 | |
| 2022-05-20 | 2022-05-18 | ELV | HAY LEWIS III | Dir | A - Grant | $0.00 | +440 | 10.1K | +5% | $0 | |
| 2022-05-20 | 2022-05-18 | ELV | CLARK R KERRY | Dir | A - Grant | $0.00 | +440 | 8,194 | +6% | $0 | |
| 2022-05-20 | 2022-05-18 | ELV | Schneider Ryan M. | Dir | A - Grant | $0.00 | +440 | 5,154 | +9% | $0 | |
| 2022-05-20 | 2022-05-18 | ELV | Neri Antonio F | Dir | A - Grant | $0.00 | +440 | 3,479 | +14% | $0 | |
| DM | 2022-03-14 | 2022-03-10 | ELV | Haytaian Peter D | EVP, Pres, DBG, IngenioRx | S - Sale+OE | $460.71 | -17.7K | 23.4K | -43% | -$8.16M |
| D | 2022-03-14 | 2022-03-10 | ELV | Haytaian Peter D | EVP, Pres, DBG, IngenioRx | M - OptEx | $131.80 | +1,848 | 29.9K | +7% | +$243.6K |
| DM | 2022-03-03 | 2022-03-01+ | ELV | Kendrick Charles Morgan JR | EVP, Pres, Commercial | F - Tax | $452.94 | -914 | 10.7K | -8% | -$414.0K |
| DM | 2022-03-03 | 2022-03-01 | ELV | Kendrick Charles Morgan JR | EVP, Pres, Commercial | A - Grant | $0.00 | +3,969 | 12.6K | +46% | $0 |
| DM | 2022-03-03 | 2022-03-01+ | ELV | Penczek Ronald W | CAO, Ctrl | F - Tax | $452.98 | -421 | 1,643 | -20% | -$190.7K |
| DM | 2022-03-03 | 2022-03-01 | ELV | Penczek Ronald W | CAO, Ctrl | A - Grant | $0.00 | +1,175 | 1,865 | +170% | $0 |
| DM | 2022-03-03 | 2022-03-03 | ELV | Penczek Ronald W | CAO, Ctrl | M - OptEx | $293.50 | +1,559 | 3,857 | +68% | +$457.6K |
| D | 2022-03-03 | 2022-03-03 | ELV | Penczek Ronald W | CAO, Ctrl | S - Sale+OE | $463.68 | -2,423 | 1,902 | -56% | -$1.12M |
| DM | 2022-03-03 | 2022-03-01 | ELV | MCCARTHY GLORIA M | EVP, Chief Administrative Off | A - Grant | $0.00 | +10.5K | 53.0K | +25% | $0 |
| DM | 2022-03-03 | 2022-03-01+ | ELV | MCCARTHY GLORIA M | EVP, Chief Administrative Off | F - Tax | $452.59 | -5,358 | 60.7K | -8% | -$2.42M |
| D | 2022-03-03 | 2022-03-02 | ELV | Gallina John E | EVP, CFO | G - Gift | $0.00 | -1,420 | 56.2K | -2% | $0 |
| DM | 2022-03-03 | 2022-03-01 | ELV | Gallina John E | EVP, CFO | A - Grant | $0.00 | +11.2K | 58.0K | +24% | $0 |
| DM | 2022-03-03 | 2022-03-01+ | ELV | Gallina John E | EVP, CFO | F - Tax | $452.58 | -4,575 | 46.9K | -9% | -$2.07M |
| DM | 2022-03-03 | 2022-03-01 | ELV | BOUDREAUX GAIL | Pres, CEO, Dir | A - Grant | $0.00 | +36.5K | 122.3K | +43% | $0 |
| DM | 2022-03-03 | 2022-03-01+ | ELV | BOUDREAUX GAIL | Pres, CEO, Dir | F - Tax | $452.66 | -17.0K | 85.8K | -17% | -$7.69M |
| DM | 2022-03-03 | 2022-03-01 | ELV | Norwood Felicia F | EVP, Pres, GBD | A - Grant | $0.00 | +9,196 | 28.9K | +47% | $0 |
| DM | 2022-03-03 | 2022-03-01+ | ELV | Norwood Felicia F | EVP, Pres, GBD | F - Tax | $452.83 | -4,014 | 19.7K | -17% | -$1.82M |
| D | 2022-03-03 | 2022-03-01 | ELV | Todt Blair Williams | EVP, CLO | F - Tax | $451.50 | -191 | 2,534 | -7% | -$86.2K |
| D | 2022-03-03 | 2022-03-01 | ELV | Todt Blair Williams | EVP, CLO | A - Grant | $0.00 | +1,883 | 4,417 | +74% | $0 |
| DM | 2022-03-03 | 2022-03-01 | ELV | Haytaian Peter D | EVP, Pres, DBG, IngenioRx | A - Grant | $0.00 | +10.5K | 20.3K | +107% | $0 |
| DM | 2022-03-03 | 2022-03-01+ | ELV | Haytaian Peter D | EVP, Pres, DBG, IngenioRx | F - Tax | $452.65 | -5,160 | 28.0K | -16% | -$2.34M |
| DM | 2022-02-08 | 2022-02-07 | ELV | Penczek Ronald W | CAO, Ctrl | M - OptEx | $258.50 | +2,763 | 2,830 | +4,124% | +$714.2K |
| D | 2022-02-08 | 2022-02-07 | ELV | Penczek Ronald W | CAO, Ctrl | S - Sale+OE | $453.48 | -2,763 | 2,012 | -58% | -$1.25M |
| 2022-01-04 | 2021-12-30 | ELV | STARK LEAH | EVP, CHRO | F - Tax | $467.15 | -482 | 12.4K | -4% | -$225.2K | |
| 2022-01-04 | 2021-12-30 | ELV | Norwood Felicia F | EVP, Pres, GBD | F - Tax | $467.15 | -1,754 | 23.3K | -7% | -$819.4K | |
| 2021-12-03 | 2021-12-01 | ELV | Todt Blair Williams | EVP, CLO | F - Tax | $404.65 | -79 | 2,725 | -3% | -$32.0K | |
| D | 2021-11-03 | 2021-11-01 | ELV | Kendrick Charles Morgan JR | EVP, Pres, Commercial | A - Grant | $0.00 | +525 | 11.5K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations